SCHEMBL7108322

SCHEMBL7108322

Nc1cccc(Nc2nc(Nc3ccc(C(=O)O)cc3)c3nc[nH]c3n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.50
PIN1 Q13526 2/20 0.48
GSK3A P49840 4/20 0.47
PTK2 Q05397 1/20 0.47
RHOA P61586 1/20 0.46
AURKA O14965 5/20 0.44
TOP2A P11388 2/20 0.43
BRAF P15056 1/20 0.43
SYK P43405 1/20 0.43
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AURKB Q96GD4 2/20 0.42
CHEK1 O14757 1/20 0.41
NTRK2 Q16620 1/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894962 0.85 BRAF (0.54) PTK2AURKABRAFSYKNPC1
SCHEMBL7106217 0.85 GSK3B (0.53) GSK3BPIN1GSK3AAURKACSNK2A1
SCHEMBL7106210 0.85 GSK3B (0.53) GSK3BPIN1GSK3AAURKACSNK2A1
SCHEMBL7104854 0.83 SMN1; SMN2 (0.56) RHOABRAFSYKCSNK2A2CSNK2B
SCHEMBL7112335 0.81 GSK3B (0.46) GSK3BPIN1GSK3AAURKATOP2A
SCHEMBL459413 0.79 IGF1R (0.51) GSK3BGSK3APTK2AURKASYK
SCHEMBL7107687 0.78 ALK (0.57) AURKANPC1RAB9ASMN1; SMN2CHEK1
SCHEMBL5891718 0.77 FLT3 (0.53) CSNK2A2CSNK2BCSNK2A1
SCHEMBL5891707 0.77 FLT3 (0.53) CSNK2A2CSNK2BCSNK2A1
SCHEMBL4893816 0.77 SMN1; SMN2 (0.59) BRAFSYKNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP claimed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO claimed
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed